Results
1 -
10 of
17
(Click
here to explore results)
- Designing Multi-Target Drugs, Chapter 18 Discovery of Multi-Target Agents for Neurological Diseases via Ligand Design. Maria Laura Bolognesi, Carlo Melchiorre, Cornelis J. Van der Schyf, Moussa Youdim
, 2012
, Pages 290-315
- Anti-aging Drugs: From Basic Research to Clinical Practice, CHAPTER 5 Pharmacogenomics and Epigenomics of Age-Related Neurodegenerative Disorders: Strategies for Drug Development. Ramón Cacabelos, Juan Carlos Carril, Oscar Teijido
, 2017
, Pages 75-141
- Mechanisms and Metal Involvement in Neurodegenerative Diseases, CHAPTER 3 Parkinson’s Disease: Involvement of Iron and Oxidative Stress. David T. Dexter
, 2013
, Pages 58-79
- Emerging Drugs and Targets for Parkinson's Disease, CHAPTER 3 Dopaminergic Treatments for Parkinson’s Disease: Light and Shadows. Nicola Simola
, 2013
, Pages 61-82
- Forensic Chemistry of Substance Misuse: A Guide to Drug Control (2), CHAPTER 9 Generic Control in Other Jurisdictions
, 2022
, Pages 127-134
- Asymmetric Functionalization of C-H Bonds, CHAPTER 1 Asymmetric C–H Bond Insertion Reactions. Wen-Ting Wu, Ze-Peng Yang, Shu-Li You
, 2015
, Pages 1-66
- Sustainable Organic Synthesis: Tools and Strategies, CHAPTER 4 Biocatalysis, an Introduction. Exploiting Enzymes as Green Catalysts in the Synthesis of Chemicals and Drugs. Domiziana Masci, Daniele Castagnolo
, 2022
, Pages 68-118
- Metal Chelation in Medicine, CHAPTER 5 Treatment of Neurodegenerative Diseases by Chelators. Roberta J. Ward, David T. Dexter, Robert R. Crichton
, 2017
, Pages 153-182
- Forensic Chemistry of Substance Misuse: A Guide to Drug Control (2), CHAPTER 14 Substances Not Listed in the International Conventions
, 2022
, Pages 173-203
- Emerging Drugs and Targets for Parkinson's Disease, CHAPTER 5 Pharmacologic Management of Dopaminergic‐Induced Dyskinesias in Parkinson’s Disease. Mildred D. Gottwald, Michael J. Aminoff
, 2013
, Pages 110-125